GlobeNewswire 2021-07-13 Zealand Pharma A/S – Transaction Under Share Repurchase Program

GlobeNewswire 2021-07-06 ZEALAND PHARMA A/S - TRANSACTIONS UNDER SHARE REPURCHASE PROGRAM

GlobeNewswire 2021-05-20 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants

GlobeNewswire 2021-05-12 Zealand Pharma receives first FDA approval and prepares for launch of Zegalogue® (dasiglucagon) inje...

GlobeNewswire 2021-05-05 Amryt Reports Record Q1 2021 Financial and Operating Results

GlobeNewswire 2021-03-25 Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilit...

GlobeNewswire 2021-03-11 Zealand Pharma: on Track for Potential First Product Launch and Establishing Commercial Operations i...

GlobeNewswire 2021-02-02 Novozymes delivers resilient full-year results despite the COVID-19 pandemic and is confident about ...

GlobeNewswire 2020-11-12 Zealand Pharma continues to advance clinical programs and commercial launch capabilities and present...

GlobeNewswire 2020-11-11 Nine-month interim report (Q3) 2020

GlobeNewswire 2020-11-05 Amryt Reports Record Q3 2020 Results - Raising FY 2020 Revenue Guidance

GlobeNewswire 2020-10-23 Orphazyme accelerates arimoclomol pre-launch activities and updates financial outlook for 2020

GlobeNewswire 2020-10-02 Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilit...

GlobeNewswire 2020-09-29 Orphazyme prices its global offering, consisting of an initial public offering of American Depositar...

GlobeNewswire 2020-08-13 Zealand Pharma announces acceleration of U.S. commercial operations through the completion of the Va...

GlobeNewswire 2020-08-06 AMRYT ANNOUNCES Q2 2020 RESULTS AND ISSUES POSITIVE REVENUE GUIDANCE FOR FY 2020

GlobeNewswire 2020-06-10 Genmab and AbbVie Announce Broad Oncology Collaboration

GlobeNewswire 2020-05-14 Zealand Pharma files New Drug Application with U.S. FDA for dasiglucagon HypoPal® rescue pen, secure...

GlobeNewswire 2020-05-11 Amryt Pharma Plc - Q1 2020 RESULTS

GlobeNewswire 2020-03-31 Årsrapport 2019

GlobeNewswire 2020-02-20 Agillic A/S presents Q4 2019 results and releases annual report for 2019

GlobeNewswire 2019-11-14 Zealand Pharma completes Phase 3 clinical program for HypoPal® rescue pen, initiates a new Phase 2 c...

GlobeNewswire 2019-11-06 Genmab Announces Financial Results for the First Nine Months of 2019

GlobeNewswire 2019-09-11 Momotaro-Gene Announces First Patient Dosed in Phase 2 Clinical Trial of MTG201 in Combination with ...